Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Articles
|
|
|
2 |
Material Type: Newsletter Articles
|
"1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors" in Patent Application Approval ProcessBiotech Week, 2014, p.1268NewsRX LLCTexto completo disponível |
|
3 |
Material Type: Newsletter Articles
|
"1-Pyrazolyl-3- Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors" in Patent Application Approval ProcessBiotech Week, 2014, p.1268NewsRX LLCTexto completo disponível |
|
4 |
Material Type: Newsletter Articles
|
"1-Pyrazolyl-3- Ureas as P38 Map Kinase Inhibitors" in Patent Application Approval ProcessBiotech Week, 2014, p.1268NewsRX LLCTexto completo disponível |
|
5 |
Material Type: Newsletter Articles
|
|
|
6 |
Material Type: Newsletter Articles
|
"4-Fluoro-4-Arylpiperdin-1-Yl Derivatives as Mu Opioid Function Moderators" in Patent Application Approval ProcessMental Health Weekly Digest, 2013, p.89NewsRX LLCTexto completo disponível |
|
7 |
Material Type: Newsletter Articles
|
AbbVie Inc.; Patent Issued for Process For The Preparation Of (S)-2-Amino-Non-8-Enoic Acid (USPTO 10,059,969)Biotech Business Week, 2018, p.5954Atlanta: NewsRxTexto completo disponível |
|
8 |
Material Type: Newsletter Articles
|
AbbVie Inc.; "Process For The Preparation Of (S)-2-Amino-Non-8-Enoic Acid" in Patent Application Approval Process (USPTO 20200325506)Respiratory Therapeutics Week, 2020, p.342Atlanta: NewsRxTexto completo disponível |
|
9 |
Material Type: Newsletter Articles
|
AbbVie Inc.; Researchers Submit Patent Application, "Process For The Preparation Of (S)-2-Amino-Non-8-Enoic Acid", for Approval (USPTO 20190048372)Biotech Business Week, 2019, p.402Atlanta: NewsRxTexto completo disponível |
|
10 |
Material Type: Newsletter Articles
|
"Acellular Bioactive Scaffold Device And Methods Of Fabrication And Treatment Relating Thereto" in Patent Application Approval Process (USPTO 20200222190)Biotech Week, 2020, p.125NewsRX LLCTexto completo disponível |